| Long-term effect of gene therapy on Leber’s congenital amaurosis JWB Bainbridge, MS Mehat, V Sundaram, SJ Robbie, SE Barker, ... New England Journal of Medicine 372 (20), 1887-1897, 2015 | 786 | 2015 |
| Topographical characterization of cone photoreceptors and the area centralis of the canine retina FM Mowat, SM Petersen-Jones, H Williamson, DL Williams, PJ Luthert, ... Molecular vision 14, 2518, 2008 | 154 | 2008 |
| The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice A Georgiadis, M Tschernutter, JWB Bainbridge, KS Balaggan, F Mowat, ... PloS one 5 (12), e15730, 2010 | 138 | 2010 |
| Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach FM Mowat, KR Gornik, A Dinculescu, SL Boye, WW Hauswirth, ... Gene therapy 21 (1), 96-105, 2014 | 120 | 2014 |
| HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia FM Mowat, UFO Luhmann, AJ Smith, C Lange, Y Duran, S Harten, ... PloS one 5 (6), e11103, 2010 | 120 | 2010 |
| RPE65 gene therapy slows cone loss in Rpe65-deficient dogs FM Mowat, AR Breuwer, JT Bartoe, MJ Annear, Z Zhang, AJ Smith, ... Gene therapy 20 (5), 545-555, 2013 | 67 | 2013 |
| Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy FM Mowat, F Gonzalez, UFO Luhmann, CA Lange, Y Duran, AJ Smith, ... The American journal of pathology 180 (4), 1726-1739, 2012 | 42 | 2012 |
| Successful Gene Therapy in Older Rpe65-Deficient Dogs Following Subretinal Injection of an Adeno-Associated Vector Expressing RPE65 MJ Annear, FM Mowat, JT Bartoe, J Querubin, SA Azam, M Basche, ... Human gene therapy 24 (10), 883-893, 2013 | 37 | 2013 |
| Gene therapy in a large animal model of PDE6A-retinitis pigmentosa FM Mowat, LM Occelli, JT Bartoe, KJ Gervais, AR Bruewer, J Querubin, ... Frontiers in neuroscience 11, 342, 2017 | 34 | 2017 |
| Evaluation of Lateral Spread of Transgene Expression following Subretinal AAV–Mediated Gene Delivery in Dogs AR Bruewer, FM Mowat, JT Bartoe, SL Boye, WW Hauswirth, ... PLoS One 8 (4), e60218, 2013 | 34 | 2013 |
| Plasma neurofilament light chain as a translational biomarker of aging and neurodegeneration in dogs WK Panek, ME Gruen, DM Murdoch, RD Marek, AF Stachel, FM Mowat, ... Molecular neurobiology 57, 3143-3149, 2020 | 28 | 2020 |
| Von Hippel-Lindau protein in the RPE is essential for normal ocular growth and vascular development CAK Lange, UFO Luhmann, FM Mowat, A Georgiadis, EL West, ... Development 139 (13), 2340-2350, 2012 | 27 | 2012 |
| Clinical therapeutic efficacy of mycophenolate mofetil in the treatment of SARDS in dogs—a prospective open‐label pilot study WM Young, A Oh, JG Williams, ML Foster, WW Miller, KF Lunn, FM Mowat Veterinary ophthalmology 21 (6), 565-576, 2018 | 26 | 2018 |
| Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis C Lange, F Mowat, H Sayed, M Mehad, L Duluc, S Piper, U Luhmann, ... Experimental eye research 147, 148-155, 2016 | 22 | 2016 |
| Early-onset progressive degeneration of the area centralis in RPE65-deficient dogs FM Mowat, KJ Gervais, LM Occelli, MJ Annear, J Querubin, ... Investigative ophthalmology & visual science 58 (7), 3268-3277, 2017 | 18 | 2017 |
| Plasma Amyloid Beta Concentrations in Aged and Cognitively Impaired Pet Dogs WK Panek, DM Murdoch, ME Gruen, FM Mowat, RD Marek, NJ Olby Molecular Neurobiology 58 (2), 483-489, 2021 | 17 | 2021 |
| Clinical findings and outcomes for dogs with uveodermatologic syndrome MK Zarfoss, CA Tusler, PH Kass, K Montgomery, CC Lim, F Mowat, ... Journal of the American Veterinary Medical Association 252 (10), 1263-1271, 2018 | 17 | 2018 |
| Use of cognitive testing, questionnaires, and plasma biomarkers to quantify cognitive impairment in an aging pet dog population G Fefer, WK Panek, MZ Khan, M Singer, HD Westermeyer, FM Mowat, ... Journal of Alzheimer's Disease 87 (3), 1367-1378, 2022 | 16 | 2022 |
| Diagnostic utility of clinical and laboratory test parameters for differentiating between sudden acquired retinal degeneration syndrome and pituitary‐dependent … A Oh, ML Foster, JG Williams, C Zheng, H Ru, KF Lunn, FM Mowat Veterinary ophthalmology 22 (6), 842-858, 2019 | 15 | 2019 |
| Safety and efficacy of topically applied 0.5% and 1% pirfenidone in a canine model of subconjunctival fibrosis HD Westermeyer, B Salmon, R Baynes, J Yeatts, A Khattab, A Oh, ... Veterinary ophthalmology 22 (4), 502-509, 2019 | 10 | 2019 |
